Ms. Global: Sweden Ends Repro Health Support for Liberia; U.K. Bans Trans People From Bathrooms; Feminists Lament Far-Right AfD Win in Germany; and More

Ms. has always understood: Feminist movements around the world hold answers to some of the U.S.’ most intractable problems. Ms. Global is taking note of feminists worldwide.

This month:
—In major blow to sexual and reproductive health and rights funding, Sweden ends aid to Liberia.
—Twelfth woman’s body found near Johannesburg increases fear of potential serial killer on the loose.
—The United Kingdom has introduced sanctions on Israeli settlements in the West Bank. They target companies and people who support services for settlement expansion and individual settlers accused of violence against Palestinians.
—Liechtenstein changes its laws to allow women to inherit the throne.

… and more.

You Deserve Better Menopause Care. Here’s How to Demand It.

“As women we have become way too comfortable with suffering,” said menopause expert Dr. Sharon Malone, MD, at a New York City book launch event for Jennifer Weiss-Wolf’s When in Menopause. “Menopause is just the last on the long train of suffering stops we’ve had.”

Weiss-Wolf’s new book makes the case for changing that, from demanding better care in the doctor’s office to fighting for policies that take women’s health seriously. As she put it during the conversation: “We’re saying we demand to be seen. We demand to be heard.”

In the following excerpt, Weiss-Wolf offers practical guidance for becoming your own best champion and receiving informed, respectful midlife healthcare.

When in Menopause: A User’s Manual and Citizen’s Guide is out Tuesday, Oct. 6, from Sheldon Press.

War on Women Report: ICE Lost Count of Detained Women’s Miscarriages; Sexual Assault Still Rampant on College Campuses; Post-Dobbs Ectopic Pregnancy Deaths on the Rise

MAGA Republicans are back in the White House, and Project 2025 is their guide: the right-wing plan to turn back the clock on women’s rights, remove abortion access, and force women into roles as wives and mothers in the “ideal, natural family structure.”

We know an empowered female electorate is essential to democracy. That’s why day after day, we stay vigilant in our goals to dismantle patriarchy at every turn. We are watching, and we refuse to go back. This is the War on Women Report.

Since our last report:
—On Wednesday, Sept. 2, Gloria Steinem, feminist, social activist and cofounder of Ms., died in her New York City home. She was 92.
—The family of Tierra Walker, who died in 2024 after she was refused a medically necessary abortion under Texas’ abortion ban, is suing Texas Attorney General Ken Paxton, the University of Texas Health Science Center at San Antonio and several of Walker’s doctors and nurses in a first-of-its-kind lawsuit.
—House Republicans have formally censured Rep. Chuck Edwards (R-N.C.) for his documented inappropriate conduct toward women staffers, including excessive unwanted attention and gifts ranging from flowers and purses to personalized handguns.
—Trump’s FCC chair, Brendan Carr, spent a decade as part of a cult that trafficked and sexually exploited children and young women, former members allege.
—Almost 200 women have died in the U.S. due to an ectopic pregnancy between 2020 and 2025.
—“Jane Doe,” a former Cornell University student, has filed a lawsuit alleging she was coerced into taking incapacitating drugs, then gang-raped by seven Chi Phi fraternity brothers over a period of several hours at their fraternity house in October 2024. The plaintiff is suing Cornell University, several fraternity and sorority organizations and the seven Chi Phi members: Matthew Ingalls, Johnathan Newell, Winston Lee, Gillio Lopes, Diego Sarabia, Scott Norris and Scott Kretzschmar.
—A jury in Lima, Ohio, has indicted a 22-year-old woman for “abuse of a corpse” after she was arrested in February when she suffered a miscarriage and placed the fetal remains in the trash.
—The same month the details of the Cornell case emerged, a student at Louisiana State University is seeking criminal charges against a student football player for allegedly sexually assaulting her in October 2025. A Title IX investigation at the university level has found that the student-athlete is “responsible” for “sexual assault” and “forcible rape.” However, an appeals judge reduced his punishment from suspension to probation.

… and more.

After Her Near-Fatal Pregnancy Crisis, Amanda Zurawski Is Finally a Mom

In 2022, Amanda Zurawski became a national figure after she nearly died from pregnancy complications in Texas. Zurawski had conceived that pregnancy through intrauterine insemination (IUI), but when her water broke at 18 weeks, doctors delayed abortion care until she developed life-threatening sepsis. The infection left severe scarring in her reproductive organs, leading her and her husband, Josh, to pursue IVF and a surrogate, who gave birth to their son, August, on Sept. 13.

“August Mikel James Zurawski was born on Sep. 13, and he is happy and healthy. We are the happiest. … For the present, we hope to stay in Texas and fight. But now we have someone else to think about.”

Antiabortion Politics Blocks Research on Fibroids, Endometriosis and Breast Cancer. The Media Is Finally Paying Attention.

Mifepristone is known as the abortion pill, but it has other uses most Americans have never heard about. For more than three decades, scientists have known this medication could do far more than end a pregnancy. Research shows mifepristone and a similar drug ulipristal acetate (sold under the brand name ella) can shrink fibroids, treat endometriosis and may treat and even prevent breast cancer.

Despite this huge potential to improve women’s health and well-being, abortion opponents have obstructed research into these treatments for decades, fearing anything that could make mifepristone more available would weaken their fight against abortion.

The burden of this obstruction has fallen on women, left to suffer from years of painful fibroids and endometriosis, heavy bleeding and reduced fertility, or death from aggressive forms of breast cancer, while research that could help sits on the shelf.

For years, the fight to unlock mifepristone’s lifesaving potential was a story only feminist media would tell, but mainstream media is finally catching up.

Abortion Belongs in Pregnancy Care—And Your Insurance Should Cover It

In the fall of 1977, Rosie Jimenez, a 27-year-old single mother in McAllen, Texas, needed an abortion. Just months earlier Medicaid would have covered the procedure. But the Hyde Amendment, a new rule banning Medicaid coverage for abortion, had just taken effect. Unable to afford the more than $200 cost of an abortion from a licensed clinician, she turned to a midwife who was technically unlicensed to preform abortions.

Jimenez died from that unsafe procedure. She is widely known as the first documented death from the Hyde Amendment.

Fifty years later, countless women across the U.S. have had their lives forever changed by this archaic, racist, sexist and classist amendment.

Decades of Male-Focused Medical Research Could Bias Healthcare AI

Many people will learn CPR using a flat-chested manikin. A 2024 study of 20 models of CPR manikins sold worldwide found that three-quarters were described as male or had no sex specified. Of the 20, only one offered a breast overlay.

The manikins reflect a wider tendency in medical teaching and research to treat the male body as standard. The terms “male and female” and “men and women” in this article reflect the sources, which often fail to distinguish sex from gender or say whether gender-diverse people were included.

The lack of female representation can have consequences. In a U.S. study of 19,331 out-of-hospital cardiac arrests, 39 percent of women who collapsed in public received bystander CPR, compared with 45 percent of men.

Medical research is becoming more representative, but much of today’s evidence was collected when male bodies were more often treated as standard. Careful design could help AI identify patterns that older research missed.

As tomorrow’s healthcare is built from yesterday’s records, researchers must ask whether an apparent difference reflects biology or the way patients encountered healthcare. Otherwise old assumptions could become embedded in new technology.

Public Health Begins With Listening: Lessons From Zambia and Malawi on Reducing Maternal Mortality

In the Zambian districts where it operated, the five-year Saving Mothers, Giving Life initiative helped reduce the maternal mortality ratio by 41 percent. Its success relied not only on expanding healthcare, but also on building trust and ensuring that interventions responded to the needs of local communities.

Charles B. Holmes, recently named dean of the University of Michigan School of Public Health, spent four years leading the Centre for Infectious Disease Research in Zambia. He credits women mentors, collaborators and successors with shaping his approach to maternal care, HIV prevention and sustainable public health systems.

As the United States faces its own maternal health crisis and the Trump administration sharply curtails foreign aid, the lessons from Zambia and Malawi are increasingly urgent: Effective public health requires local leadership, long-term investment and the voices of those most affected at the table.

Half the Country, a Fraction of the Research

For decades, Democratic and Republican administrations alike presided over a medical research system that routinely excluded women. The result? Modern medicine was built on incomplete science—and women are still paying the price. 

It wasn’t until the NIH Revitalization Act of 1993 that federally funded clinical trials were required to include women. Yet changing who participates in research does not rewrite decades of medical knowledge overnight. By then, physicians had already been trained using male-centered evidence, diagnostic standards had been established, and countless drugs had already been dosed using evidence derived solely from men.  

In 2025, the Trump administration has proposed cutting the NIH’s budget by roughly 43 percent (equivalent to $20 billion per year). Its broader HHS budget proposal called for eliminating or consolidating several programs supporting family planning and maternal and child health. Federal agencies also came under pressure to scrutinize or reject grant proposals containing terms such as women, leading to paused or cancelled fellowships and research on conditions such as uterine fibroids and pregnancy. 

There are signs, however, that Congress may finally be beginning to treat women’s health across the lifespan as a serious policy issue.

On Sept. 16, the Senate Special Committee on Aging will hold Congress’ first-ever hearing devoted to menopause. Led by ranking member Sen. Kirsten Gillibrand (D-N.Y.), “Half the Country, Zero Hearings: Meeting the Moment to End the Menopause Care Gap in America” will examine the nation’s lack of menopause research, informed medical care and provider training—and make the case for greater federal investment.

The hearing represents an overdue step forward. But women’s health cannot remain vulnerable to political cycles. Regardless of which party holds power, it must become a permanent priority within American policy and medicine.